Xencor (XNCR) Capital Leases (2013)
Xencor (XNCR) posted quarterly Capital Leases of $1000.0 for Q4 2013.
Powered by 
Analysis
Xencor (XNCR) Capital Leases (2013) Analysis & Trends
Xencor (XNCR) has reported Capital Leases for 1 consecutive years, with $1000.0 the latest figure, recorded in Q4 2013.
- In Q4 2013, Capital Leases changed N/A year-over-year to $1000.0; the TTM figure through Dec 2013 stood at $1000.0 (changed N/A YoY), while the FY2013 annual figure was $1000.0, changed N/A from the prior year.
- Capital Leases held at $1000.0 in Q4 2013 per XNCR's latest filing.
- Across five years, Capital Leases topped out at $1000.0 in Q4 2013 and bottomed at $1000.0 in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - |